Literature DB >> 2150084

Glomeruli synthesize nitrite in experimental nephrotoxic nephritis.

V Cattell1, T Cook, S Moncada.   

Abstract

Activated macrophages synthesize nitric oxide (NO) from L-arginine. In culture, the major stable end product is nitrite (NO2). Activated macrophages accumulate in glomeruli and are responsible for injury in experimental immune complex glomerulonephritis. We examined NO2- production by isolated glomeruli and urinary NO2- in accelerated nephrotoxic nephritis in the rat. Normal glomeruli did not produce NO2- spontaneously or when stimulated with lipopolysaccharide (LPS) (1 microgram/ml) or A23187 (2 microgram/ml). Cultured mesangial cells at first or seventh passage did not produce NO2- spontaneously or when stimulated. Nephritic glomeruli spontaneously produced NO2 at all times studied; this production was maximal at 24 hours after induction of glomerulonephritis (158.4 +/- 8.4 nmol/48 hr/ml, N = 3). The production of NO2- was inhibited 75 to 100% by NG-monomethyl-L-arginine (L-NMMA), and this inhibition was reversed by L-arginine, indicating NO2- production from L-arginine via NO. The production of NO2- was increased by LPS (1 microgram/ml) at 2, 7 and 21 days. NO2- was undetectable in normal rat urine; however, it was present in urine of rats with glomerulonephritis (Day 0 to 1:8161 +/- 2605 nmol/24 hr. N = 12). The production of NO in nephritic glomeruli may have implications for both the mechanism of glomerular injury and glomerular hemodynamics.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2150084     DOI: 10.1038/ki.1990.312

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  22 in total

1.  Macrophages from inflamed but not normal glomeruli are unresponsive to anti-inflammatory cytokines.

Authors:  L P Erwig; K Stewart; A J Rees
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

2.  Induced nitric oxide (NO) synthesis in heterologous nephrotoxic nephritis; effects of selective inhibition in neutrophil-dependent glomerulonephritis.

Authors:  S N Waddington; K Mosley; V Cattell
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

Review 3.  Inducible nitric oxide synthase in inflammation.

Authors:  V Cattell; A Jansen
Journal:  Histochem J       Date:  1995-10

Review 4.  An evaluation of experimental models of glomerulonephritis.

Authors:  P N Furness; K Harris
Journal:  Int J Exp Pathol       Date:  1994-02       Impact factor: 1.925

5.  Regulation of prostaglandin production by nitric oxide; an in vivo analysis.

Authors:  D Salvemini; S L Settle; J L Masferrer; K Seibert; M G Currie; P Needleman
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

6.  L-arginine may mediate the therapeutic effects of low protein diets.

Authors:  I Narita; W A Border; M Ketteler; E Ruoslahti; N A Noble
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

7.  Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. Evidence for protein kinase C-mediated suppression of the cholinergic response.

Authors:  P A Craven; R K Studer; F R DeRubertis
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

8.  Preventive effect of sulphated colominic acid on P-selectin-dependent infiltration of macrophages in experimentally induced crescentic glomerulonephritis.

Authors:  D Ogawa; K Shikata; M Matsuda; S Okada; J Wada; S Yamaguchi; Y Suzuki; M Miyasaka; S Tojo; H Makino
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

9.  Glomerular nitrite synthesis in in situ immune complex glomerulonephritis in the rat.

Authors:  H T Cook; R Sullivan
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

10.  Evidence suggesting a nitric oxide-scavenging activity for traditional crude drugs, and action mechanisms of Sanguisorbae Radix against oxidative stress and aging.

Authors:  T Yokozawa; C P Chen
Journal:  J Am Aging Assoc       Date:  2001-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.